# Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

> **NCT01433289** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 23 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Polyphenon E
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01433289
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2014-08
- **Final completion:** 2015-07
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01433289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01433289, "Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01433289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*